Literature DB >> 33443102

Protein kinase Cα regulates the nucleocytoplasmic shuttling of KRIT1.

Elisa De Luca1,2,3, Andrea Perrelli4,2, Harsha Swamy5, Mariapaola Nitti6, Mario Passalacqua6, Anna Lisa Furfaro6, Anna Maria Salzano7, Andrea Scaloni7, Angela J Glading8, Saverio Francesco Retta1,2.   

Abstract

KRIT1 is a scaffolding protein that regulates multiple molecular mechanisms, including cell-cell and cell-matrix adhesion, and redox homeostasis and signaling. However, rather little is known about how KRIT1 is itself regulated. KRIT1 is found in both the cytoplasm and the nucleus, yet the upstream signaling proteins and mechanisms that regulate KRIT1 nucleocytoplasmic shuttling are not well understood. Here, we identify a key role for protein kinase C (PKC) in this process. In particular, we found that PKC activation promotes the redox-dependent cytoplasmic localization of KRIT1, whereas inhibition of PKC or treatment with the antioxidant N-acetylcysteine leads to KRIT1 nuclear accumulation. Moreover, we demonstrated that the N-terminal region of KRIT1 is crucial for the ability of PKC to regulate KRIT1 nucleocytoplasmic shuttling, and may be a target for PKC-dependent regulatory phosphorylation events. Finally, we found that silencing of PKCα, but not PKCδ, inhibits phorbol 12-myristate 13-acetate (PMA)-induced cytoplasmic enrichment of KRIT1, suggesting a major role for PKCα in regulating KRIT1 nucleocytoplasmic shuttling. Overall, our findings identify PKCα as a novel regulator of KRIT1 subcellular compartmentalization, thus shedding new light on the physiopathological functions of this protein.
© 2021. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Cerebral cavernous malformation; KRIT1; Nucleocytoplasmic shuttling; PKC signaling; PKCα; PKCδ; Phorbol esters; Phosphoproteomics; Redox signaling

Mesh:

Substances:

Year:  2021        PMID: 33443102      PMCID: PMC7875496          DOI: 10.1242/jcs.250217

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  100 in total

1.  Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain.

Authors:  M A Pearson; D Reczek; A Bretscher; P A Karplus
Journal:  Cell       Date:  2000-04-28       Impact factor: 41.582

2.  Nuclear Localization of Integrin Cytoplasmic Domain-associated Protein-1 (ICAP1) Influences β1 Integrin Activation and Recruits Krev/Interaction Trapped-1 (KRIT1) to the Nucleus.

Authors:  Kyle M Draheim; Clotilde Huet-Calderwood; Bertrand Simon; David A Calderwood
Journal:  J Biol Chem       Date:  2016-12-21       Impact factor: 5.157

3.  Structural basis for the disruption of the cerebral cavernous malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutations.

Authors:  Oriana S Fisher; Weizhi Liu; Rong Zhang; Amy L Stiegler; Sondhya Ghedia; James L Weber; Titus J Boggon
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

4.  Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations.

Authors:  R E Clatterbuck; C G Eberhart; B J Crain; D Rigamonti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-08       Impact factor: 10.154

Review 5.  Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase.

Authors:  Toyoshi Inoguchi; Toshiyo Sonta; Hirotaka Tsubouchi; Takashi Etoh; Maiko Kakimoto; Noriyuki Sonoda; Naoichi Sato; Naotaka Sekiguchi; Kunihisa Kobayashi; Hideki Sumimoto; Hideo Utsumi; Hajime Nawata
Journal:  J Am Soc Nephrol       Date:  2003-08       Impact factor: 10.121

6.  Structural basis for small G protein effector interaction of Ras-related protein 1 (Rap1) and adaptor protein Krev interaction trapped 1 (KRIT1).

Authors:  Xiaofeng Li; Rong Zhang; Kyle M Draheim; Weizhi Liu; David A Calderwood; Titus J Boggon
Journal:  J Biol Chem       Date:  2012-05-10       Impact factor: 5.157

7.  Multifunctional Platinum@BSA-Rapamycin Nanocarriers for the Combinatorial Therapy of Cerebral Cavernous Malformation.

Authors:  Elisa De Luca; Deborah Pedone; Mauro Moglianetti; Daniele Pulcini; Andrea Perrelli; Saverio Francesco Retta; Pier Paolo Pompa
Journal:  ACS Omega       Date:  2018-11-13

Review 8.  Mechanisms for redox-regulation of protein kinase C.

Authors:  Susan F Steinberg
Journal:  Front Pharmacol       Date:  2015-06-23       Impact factor: 5.810

9.  qPhos: a database of protein phosphorylation dynamics in humans.

Authors:  Kai Yu; Qingfeng Zhang; Zekun Liu; Qi Zhao; Xiaolong Zhang; Yan Wang; Zi-Xian Wang; Ying Jin; Xiaoxing Li; Ze-Xian Liu; Rui-Hua Xu
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

10.  Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1.

Authors:  Hélène Choquet; Eliana Trapani; Luca Goitre; Lorenza Trabalzini; Amy Akers; Marco Fontanella; Blaine L Hart; Leslie A Morrison; Ludmila Pawlikowska; Helen Kim; Saverio Francesco Retta
Journal:  Free Radic Biol Med       Date:  2016-01-19       Impact factor: 7.376

View more
  5 in total

Review 1.  Cerebral Cavernous Malformation Pathogenesis: Investigating Lesion Formation and Progression with Animal Models.

Authors:  Chelsea M Phillips; Svetlana M Stamatovic; Richard F Keep; Anuska V Andjelkovic
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

2.  Contribution of protein-protein interactions to the endothelial-barrier-stabilizing function of KRIT1.

Authors:  Harsha Swamy; Angela J Glading
Journal:  J Cell Sci       Date:  2022-01-25       Impact factor: 5.235

Review 3.  Is Location Everything? Regulation of the Endothelial CCM Signaling Complex.

Authors:  Harsha Swamy; Angela J Glading
Journal:  Front Cardiovasc Med       Date:  2022-07-11

4.  Next-Generation Sequencing Advances the Genetic Diagnosis of Cerebral Cavernous Malformation (CCM).

Authors:  Valerio Benedetti; Rosalia Canzoneri; Andrea Perrelli; Carlo Arduino; Andrea Zonta; Alfredo Brusco; Saverio Francesco Retta
Journal:  Antioxidants (Basel)       Date:  2022-06-29

5.  Heterozygous Loss of KRIT1 in Mice Affects Metabolic Functions of the Liver, Promoting Hepatic Oxidative and Glycative Stress.

Authors:  Raffaella Mastrocola; Eleonora Aimaretti; Gustavo Ferreira Alves; Alessia Sofia Cento; Claudia Fornelli; Federica Dal Bello; Chiara Ferraris; Luca Goitre; Andrea Perrelli; Saverio Francesco Retta
Journal:  Int J Mol Sci       Date:  2022-09-22       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.